RIGEL PHARMACEUTICALS, INC. (RIGL) Net income 2016–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$367.0MFY2025 · since FY2016: -$69.2M → $367.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $367.0M | +1999.1% |
| FY2024 | $17.5M | +169.7% |
| FY2023 | -$25.1M | +57.2% |
| FY2022 | -$58.6M | -227.0% |
| FY2021 | -$17.9M | +39.8% |
| FY2020 | -$29.7M | +55.5% |
| FY2019 | -$66.9M | +5.1% |
| FY2018 | -$70.5M | +9.6% |
| FY2017 | -$78.0M | -12.7% |
| FY2016 | -$69.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice